BSE
MARKET ANALYSIS NEWS CORPORATE INFORMATION CORPORATE ACTIONS OTHER MARKETS
Your Result on : Company News Details
Evonile Pharma Ltd Industry :  Pharmaceuticals - Multinational
BSE Code
500672
ISIN Demat
INE234A01025
Book Value (Rs)
473.5688747
NSE Symbol
EVONILE
Divident Yield %
1.16
Market Cap
(Rs In Cr.)
5,318
P/E (TTM)
82.76
EPS (TTM)
18.37
Face Value
(Rs)
5
Back
Novartis India reports standalone net loss of Rs 77.54 crore in the September 2026 quarter
04-Nov-26   Hrs IST

Net loss of Novartis India reported to Rs 77.54 crore in the quarter ended September 2026 as against net profit of Rs 24.22 crore during the previous quarter ended September 2025. Sales declined 37.95% to Rs 56.05 crore in the quarter ended September 2026 as against Rs 90.33 crore during the previous quarter ended September 2025.

ParticularsQuarter Ended
Sep. 2026Sep. 2025% Var.
Sales56.0590.33 -38
OPM %-56.7726.44 -
PBDT-28.9133.17 PL
PBT-32.8032.65 PL
NP-77.5424.22 PL

Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
BSE Delayed market data sourced at 5 minutes – www.bseindia.com
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
Ganesh S Shanbhag – AMFI Registered Mutual Fund Distributor. Registration Number – ARN-0988 – Valid Till 01/JUL/ 2027, Date of initial registration: 02/DEC/2004
2017-18 © SMS Financial Services. All rights reserved. Designed, Developed , Maintained and Content Powered by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)